Breaking New Ground: TMS and AAAAI Award $60,000 Grant to Advance Mast Cell Disease Research

One of the most exciting and impactful things that TMS has the opportunity to do during the AAAAI meeting is to give out our joint grant award in partnership with the AAAAI.   We give this award out in odd-numbered years at AAAAI meetings, meaning that this year’s 2025 AAAAI meeting was another opportunity to contribute funds to advance mast cell science!

We were thrilled to join with our partners at AAAAI to award a $60,000 research grant to Dr. Eric Oliver (Johns Hopkins Hospital) in support of his research on the role of the MRGPRX2 receptor in mast cell activation. This study has the potential to uncover critical insights into mast cell disorders (MCDs) and their connection to drug-induced anaphylaxis, ultimately guiding the development of targeted treatments for patients living with these conditions.

MRGPRX2 is a receptor found on mast cells and certain neurons, and it is known to be activated by specific triggers, potentially playing a key role in mast cell activation. Recent hypotheses suggest that an increased burden of mast cells, and therefore MRGPRX2 receptors, in mast cell diseases may contribute to heightened anaphylactic responses to certain drugs. Dr. Oliver’s research aims to investigate whether individuals with MCDs exhibit increased responsiveness to MRGPRX2 triggers compared to healthy individuals.

If findings confirm that MCD patients exhibit heightened MRGPRX2-mediated histamine release, Dr. Oliver will expand his research to explore additional mediators and compare results with clinical characteristics, such as history of anaphylaxis, serum tryptase levels, and genetic markers like the KIT D816V mutation.

TMS is proud to support this vital research, which has the potential to revolutionize our understanding of mast cell disorders and bring new hope to patients. Dr. Oliver’s work could pave the way for novel therapeutic approaches that significantly improve the lives of those affected by MCD.

For more information about this research or TMS and AAAAI’s ongoing efforts to advance mast cell disease research and patient care, please visit https://tmsforacure.org/research-updates/